Skip to main content
Premium Trial:

Request an Annual Quote

Miltenyi Buys Cell Sorting Firm Owl Biomedical

NEW YORK (GenomeWeb News) – German firm Miltenyi Biotec today announced it has completed its acquisition of microchip cell sorting company Owl Biomedical for an undisclosed amount.

Based in Santa Barbara, Calif., Owl was founded in 2011. Its first product, called the Nanosorter, uses a closed fluid path cartridge for "plug and play" cell sorting. The technology can process samples efficiently in a clean environment isolated from the laboratory setting, Miltenyi said.

"This acquisition combines Owl's innovative microchip-based, high speed cell sorting technology and intellectual property with Miltenyi Biotec's strength in commercial design, manufacturing and marketing," John Foster, president of Owl, said in a statement. "This combination provides assurance that our technology will get to market in a timely manner with the highest quality engineering."

Based in Bergisch Gladbach, Germany, Miltenyi provides products and services for biomedical research.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.